| abstract |
FIELD: medicine; pharmaceuticals. n SUBSTANCE: group of inventions refers to pharmaceutics and dermatology, namely: to a topical composition for preventing, relieving symptoms or treating skin diseases or disorders containing from 0.015 to 0.035 wt. % of clobetasol in a solution of monoethyl ether of diethylene glycol, which serves as an intensifier of penetration, an aqueous phase and an oil phase; as well as to a method for preventing, reducing the intensity of symptoms or treating a painful skin condition involving the use of an effective amount of said composition on an individual. n EFFECT: group of inventions provides reducing side effects by reducing the amount of active substance while maintaining therapeutic effectiveness by improving its penetration through skin. n 15 cl, 8 dwg, 11 ex, 16 tbl |